This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Arbutus Biopharma Corporation. Active years: 2022-2024.
Company Filing History:
Years Active: 2022-2024
Title: The Innovations of Jeffrey P. Bechard
Introduction
Jeffrey P. Bechard is an accomplished inventor based in Surrey, Canada. He has made significant contributions to the field of biopharmaceuticals, particularly in methods for ameliorating infusion reactions. With a total of 2 patents to his name, Bechard's work is recognized for its potential impact on medical treatments.
Latest Patents
Bechard's latest patents focus on innovative methods for ameliorating infusion reactions. These patents provide certain embodiments of the invention that offer methods to alleviate infusion reactions in mammals in need thereof. This research is crucial for improving patient outcomes during medical treatments that involve infusions.
Career Highlights
Jeffrey P. Bechard is currently associated with Arbutus Biopharma Corporation, where he continues to develop and refine his innovative ideas. His work at the company emphasizes the importance of addressing adverse reactions in medical therapies, showcasing his commitment to enhancing patient care.
Collaborations
One of his notable collaborators is Wayne J. Wallis, with whom he has worked closely on various projects. Their partnership highlights the collaborative nature of innovation in the biopharmaceutical industry.
Conclusion
Jeffrey P. Bechard's contributions to the field of biopharmaceuticals through his patents and collaborations demonstrate his dedication to improving medical treatments. His work continues to pave the way for advancements in patient care and therapeutic methods.